Qiuping Zhou

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy

P. Marrack, J. Kappler, Peng Bai, 2019, bioRxiv.

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy

P. Marrack, J. Kappler, Peng Bai, 2019, bioRxiv.

Rational discovery of a cancer neoepitope harboring the KRAS G12D driver mutation

P. Marrack, J. Kappler, H. Bai, 2021, Science China Life Sciences.

p53 Tumor Suppressor Gene Mutation in Early Esophageal Precancerous Lesions and Carcinoma among High-Risk Populations in Henan, China1

Gao, Chung S. Yang, Wang, 2006 .

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy

P. Marrack, J. Kappler, Peng Bai, 2021, Oncoimmunology.

Characters of neoantigens in cancer immunotherapy

P. Marrack, J. Kappler, Peng Bai, 2020 .

Characters of neoantigens in cancer immunotherapy 1

P. Marrack, J. Kappler, Peng Bai, 2019 .